In Vivo Target Validation: Methodology and Case Studies on the Janus Kinase Tyk2

E-ISSN： 1875-614x|6|1|29-45

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.6, Iss.1, 2007-01, pp. : 29-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 268-294

Bentham Science Publishers

Access to resources Recommend Favorite

Janus kinase 2 inhibitors in myeloproliferative disorders

By Lucia Eugenio Recchia Anna Grazia Gentile Massimo Bossio Sabrina Vigna Ernesto Mazzone Carla Madeo Antonio Morabito Lucio Gigliotti Vincenzo Stefano Laura De Caruso Nadia Servillo Pasquale Franzese Stefania Bisconte Maria Grazia Gentile Carlo Morabito Fortunato

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 41-59

Informa Healthcare

Access to resources Recommend Favorite

Janus kinase 3: a novel target for selective transplant immunosupression

By Podder Hemangshu Kahan Barry D

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 613-629

Informa Healthcare

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors

Letters in Drug Design & Discovery, Vol. 15, Iss. 2, 2018-01 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational Janus kinase inhibitors

By Tam Constantine S

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 687-699

Informa Healthcare

Access to resources Recommend Favorite